Tools on the Horizon for Managing Posttransplant cSCC Risk
Organ transplant recipients have a 200-fold increased incidence of keratinocyte carcinoma compared with immunocompetent individuals, and cSCC accounts for 80% of skin cancers in those recipients. (Source: Medscape Transplantation Podcast)
Source: Medscape Transplantation Podcast - February 9, 2024 Category: Transplant Surgery Authors: Medscape 210869 Source Type: podcasts
Toripalimab for Nasopharyngeal Carcinoma, Cervical Cancer Screening Strategies, Obesity Review, and more
Editor’s Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the November 28, 2023, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - November 28, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Surgery : Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS
Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 23, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Genetic Profiling Identifies High-Risk Tumors in Cutaneous Squamous Cell Carcinoma
(Source: Medscape Transplantation Podcast)
Source: Medscape Transplantation Podcast - June 7, 2023 Category: Transplant Surgery Authors: Medscape 210869 Source Type: podcasts
JAMA Otolaryngology –Head & Neck Surgery : American Thyroid Association Guidelines and Management of Papillary Thyroid Carcinoma
Interview with Babak Givi, MD, author of American Thyroid Association Guidelines and National Trends in Management of Papillary Thyroid Carcinoma. Hosted by Paul C. Bryson, MD, MBA. Related Content: American Thyroid Association Guidelines and National Trends in Management of Papillary Thyroid Carcinoma (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - November 3, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Otolaryngology –Head & Neck Surgery : Use of Intraoperative Frozen Section Controls During Transoral Robotic Surgery for Oropharyngeal Cancer
Interview with Abie H. Mendelsohn, MD, author of Association of Intraoperative Frozen Section Controls With Improved Margin Assessment During Transoral Robotic Surgery for Human Papillomavirus–Positive Oropharyngeal Squamous Cell Carcinoma.Hosted by Paul C. Bryson, MD, MBA. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - September 22, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Radiotherapy With vs Without Chemotherapy for Nasopharyngeal Carcinoma, Trends in Lipids Concentrations in US Adults, USPSTF Recommendation Statement on Statin Use, and more
Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the August 23/30, 2022 issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - August 23, 2022 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Otolaryngology –Head & Neck Surgery : Use of Tumor Bed Frozen Section to Assess Final Tumor Margin in Oral Cavity Carcinoma
Interview with Snehal G. Patel, MD, author of Use of Intraoperative Frozen Section to Assess Final Tumor Margin Status in Patients Undergoing Surgery for Oral Cavity Squamous Cell Carcinoma. Hosted by Paul C. Bryson, MD, MBA. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - August 4, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Oncology : Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Interview with David Anthony Palma, MD, PhD, and Anthony C. Nichols, MD, authors of Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - April 28, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Dermatology : Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis
Interview with Paul Nghiem, MD, PhD, author of Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis. Hosted by Adewole S. Adamson, MD, MPP. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 23, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Oncology : Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
Interview with Robert J. Motzer, MD, author of Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma. Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - December 23, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Dermatology : Multiple vs First Incidence of Cutaneous Squamous Cell Carcinoma and Estimation of Future Incidences
Interview with Marlies Wakkee, MD, PhD, author of Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 28, 2020 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Oncology : Five-Year Survival Among Patients With Advanced Skin, Renal, and Lung Cancer Treated With Nivolumab
Interview with Suzanne L. Topalian, author of Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - July 25, 2019 Category: General Medicine Source Type: podcasts
Most Anticipated Trial Results Regarding Biomarkers in RCC
Tian Zhang , MD, Assistant Professor of Medicine, Duke Cancer Institute, explains the anticipated trial results involving I-O, TKIs and biomarkers in renal cell carcinoma (RCC).
Author: obr
Added: 07/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 2, 2019 Category: Cancer & Oncology Source Type: podcasts
